Compact, power-efficient architectures using microvalves and microsensors, for intrathecal, insulin, and other drug delivery systems

Advanced Drug Delivery Reviews

Volumn 64, Issue 14, 2012, Pages 1639-1649

  Li, Tao ^a   Evans, Allan T ^a,c   Chiravuri, Srinivas ^b   Gianchandani, Roma Y ^b   Gianchandani, Yogesh B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

Implantable drug pump; Liquid flow control; MEMS; Microvalve manifold; Multidrug delivery; Piezoelectric; Power transfer; Wearable drug pump

Indexed keywords

LIQUID FLOW; MICRO VALVES; MULTIDRUG DELIVERY; PIEZOELECTRIC; POWER TRANSFERS;

DRUG DELIVERY; INSULIN; MEMS; PRESSURE SENSORS;

VALVES (MECHANICAL);

CLONIDINE; INSULIN; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; STEROID;

ANALGESIA; CHRONIC PAIN; COUNSELING; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; FLOW RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HUMAN; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; MAGNETIC FIELD; NERVE BLOCK; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOTIC PRESSURE; PHYSIOTHERAPY; PIEZOELECTRICITY; PRIORITY JOURNAL; RESERVOIR; REVIEW;

DIABETES MELLITUS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; INJECTIONS, SPINAL; INSULIN; MICROTECHNOLOGY;

EID: 84868192686     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.05.002     Document Type: Review

References (105)

1. Joint Committee on Accreditation of Healthcare Organizations New standards to assess and manage pain. Jt. Comm. Perspect. 1999, 19.
2. Phillips C.J. Pain management: health economics and quality of life considerations. Drugs 2003, 63.
3. Harstall C., Ospina M. How prevalent is chronic pain?. Pain: Clinical Updates, Online Newsletter of International Association for the Study of Pain Jun. 2003, http://www.iasp-pain.org.
4. Rainov N.G., Heidecke V. Management of chronic back and leg pain by intrathecal drug delivery. Acta Neurochir. Suppl. 2007, 97.
5. Turner J.A., Sears J.M., Loeser J.D. Programmable intrathecal opioid delivery systems for chronic noncancer pain: a systematic review of effectiveness and complications. Clin. J. Pain 2007, 23:180-195.
6. Krames E.S., Olson K. Clinical realities and economic considerations: patient selection in intrathecal therapy. J. Pain Symptom Manage. 1997, 14:S3-S13.
7. Winkelmuller M., Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J. Neurosurg. 1996, 85:458-467.
8. Wermeling D.P. Ziconotide an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain. Pharmacotherapy 2005, 25:1084-1094.
9. Schug S.A., Saunders D., Kurowski I., Paech M.J. Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia. CNS Drugs 2006, 20.
10. Rauck R.L., Cherry D., Boyer M.F., Kosek P., Dunn J., Alo K. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J. Pain 2003, 4.
11. Deer T., Chapple I., Classen A., Javery K., Stoker V., Tonder L., Burchiel K. Intrathecal drug delivery for treatment of chronic low back pain: report from the National Outcomes Registry for Low Back Pain. Pain Med. 2004, 5.
12. Erdine S., Andres J.D. Drug delivery systems. Pain Pract. 2006, 6.
13. Likar R., Ilias W., Kloimstein H., Kofler A., Kress H.G., Neuhold J., Pinter M.M., Spendel M.C. Importance of intrathecal pain therapy. Der Schmerz 2007, 21:15-27.
14. Krames E.S. Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines. J. Pain Symptom Manage. 1996, 11:333-352.
15. Lamer T.J. Treatment of cancer-related pain: when orally administered medications fail. Mayo Clin. Proc. 1994, 69:473-480.
16. Crawford J.S. Site of action of intrathecal morphine. Br. Med. J. 1980, 281.
17. Baraka A. Rostral spread of intrathecal morphine in man. Middle East J. Anaesthesiol. 1982, 6.
18. Dobrydnjov I., Axelsson K., Gupta A., Lundin A., Holmström B., Granath B. Improved analgesia with clonidine when added to local anesthetic during combined spinal-epidural anesthesia for hip arthroplasty: a double-blind, randomized and placebo-controlled study. Acta Anaesthesiol. Scand. 2005, 49:538-545.
19. Strebel S., Gurzeler J.A., Schneider M.C., Aeschbach A., Kindler C.H. Small-dose intrathecal clonidine and isobaric bupivacaine for orthopedic surgery: a dose-response study. Anesth. Analg. 2004, 99:1231-1238.
20. Ackerman L.L., Follett K.A., Rosenquist R.W. Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. J. Pain Symptom Manage. 2003, 26:668-677.
21. Rainov N.G., Heidecke V., Burkert W. Long-term intrathecal infusion of drug combinations for chronic back and leg pain. J. Pain Symptom Manage. 2001, 22:862-871.
22. Deer T.R., Caraway D.L., Kim C.K., Dempsey C.D., Stewart C.D., McNeil K.F. Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine. Spine J. 2002, 2.
23. Uhle E.I., Becker R., Gatscher S., Bertalanffy H. Continuous intrathecal clonidine administration for the treatment of neuropathic pain. Stereotact. Funct. Neurosurg. 2000, 75:167-175.
24. Wallace M.S., Rauck R., Fisher R., Charapata S.G., Ellis D., Dissanayake S., Group Z.-S. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial. Anesth. Analg. 2008, 106:628-637.
25. Webster L.R., Fakata K.L., Charapata S., Fisher R., MineHart M. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain. Pain Med. 2008, 9:282-290.
26. Sakurada T., Komatsu T., Sakurada S. Mechanisms of nociception evoked by intrathecal high-dose morphine. Neurotoxicology 2005, 26.
27. Mercadante S., Portenoy R.K. Opioid poorly-responsive cancer pain. J. Pain Symptom Manage. 2001, 21.
28. Mercadante S., Ferrera P., Villari P., Arcuri E. Hyperalgesia: an emerging iatrogenic syndrome. J. Pain Symptom Manage. 2003, 26.
29. Shaw J.E., Sicreea R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010, 87:4-14.
30. International Diabetes Federation IDF Diabetes Atlas 2009, http://www.diabetesatlas.org. 4th ed.
31. Boyle J.P., Thompson T.J., Gregg E.W., Barker L.E., Williamson D.F. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul. Health Metr. 2010, 8:29.
32. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197.
33. Follow-up report on the diagnosis of diabetes mellitus - the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
34. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993, 329:977-986.
35. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853.
36. Castle J.R., Engle J.M., Youssef J.E., Massoud R.G., Yuen K.C.J., Kagan R., Ward W.K. Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care 2010, 33:1282-1287.
37. Aronoff S.L., Berkowitz K., Shreiner B., Want L. Glucose metabolism and regulation: beyond insulin and glucagon. Diabetes Spectr. 2004, 17:183-190.
38. Hassenbusch S.J., Portenoy R.K., Cousins M., Buchser E., Deer T.R., Pen S.L.D., Eisenach J., Follett K.A., Hildebrand K.R., Krames E.S., Levy R.M., Palmer P.P., Rathmell J.P., Rauck R.L., Staats P.S., Stearns L., Willis K.D. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery - report of an expert panel. J. Pain Symptom Manage. 2004, 27.
39. Krames E.S. Practical issues when using neuraxial infusion. Oncology 1999, 13.
40. Grabow T.S., Derdzinski D., Staats P.S. Spinal drug delivery. Curr. Pain Headache Rep. 2001, 5.
41. Anderson V.C., Burchiel K.J. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. Neurosurgery 1999, 44.
42. American Society of Health System Pharmacists ASHP guidelines on quality assurance for pharmacy-prepared sterile products. Am. J. Health Syst. Pharm. 2000, 57.
43. Coombs D.W., Fine N. Spinal anesthesia using subcutaneously implanted pumps for intrathecal drug infusion. Anesth. Analg. 1991, 73.
44. Medtronic IsoMed Constant Flow Intrathecal Drug Delivery Pump 2011, http://professional.medtronic.com/pt/neuro/idd/prod/isomed/index.htm, Accessed Aug. 2011.
45. CODMAN 3000 pump Accessed Aug. 2011. http://www.codmanpumps.com/.
46. Medtronic SynchroMed II intrathecal drug delivery pump Accessed Aug. 2011. http://professional.medtronic.com/pt/neuro/idd/prod/synchromed-ii/index.htm.
47. Medtronic SynchroMed EL intrathecal drug delivery pump Accessed Aug. 2011. http://professional.medtronic.com/pt/neuro/idd/prod/synchromed-el/index.htm.
48. Evans A.T., Chiravuri S., Gianchandani Y.B. A low power, microvalve regulated architecture for drug delivery systems. Biomed. Microdevices 2010, 12:159-168.
49. A.T. Evans, Valve Regulated Implantable Drug Delivery for Chronic Pain Management, Ph.D. Thesis, University of Michigan, Ann Arbor, MI, USA, 2010.
50. Lobato E.B., Gravenstein N., Kirby R.R. Complications in Anesthesiology 2007, Lippincott Williams & Wilkins.
51. Current diabetes insulin pumps and comparison chart Accessed Aug. 2011. http://www.diabetesnet.com/diabetes-technology/insulin-pumps/current-pumps/pump-comparison.
52. Medtronic MiniMed paradigm revel insulin pump Accessed Jun. 2011. http://www.minimed.com/.
53. OneTouch Ping Accessed Aug. 2011. http://www.animas.com/animas-insulin-pumps/onetouch-ping.
54. OmniPod insulin pump Accessed Jun. 2011. http://www.myomnipod.com/.
55. Sooil Dana Diabecare insulin pumps Accessed Jun. 2011. http://www.sooil.com/.
56. Deltec Cozmo insulin pump Accessed Jul. 2011. http://www.smiths-medical.com/landing-pages/promotions/md/coz-home.html.
57. ACCU-CHEK Spirit Insulin Pump Accessed Jul. 2011. http://www.accu-chekinsulinpumps.com/ipus/products/insulinpumps/index.html.
58. Spring Zone Insulin Pump Accessed Aug. 2011. http://www.springnow.com.
59. Pancreum artificial pancreas system Accessed Aug. 2011. http://www.pancreum.com.
60. GlobalData, insulin pump world market briefing Aug. 2010. http://www.mtbeurope.info/content/ft1008001.htm.
61. Evans A.T., Chiravuri S., Gianchandani Y.B. A multidrug delivery system using a piezoelectrically actuated silicon valve manifold with embedded sensors. IEEE/ASME J. Microelectromech. Syst. 2011, 20:231-238.
62. Shinozawa Y., Abe T., Kondo T. A proportional microvalve using a bi-stable magnetic actuator. Proceedings of the IEEE International Conference on Micro Electro Mechanical Systems (MEMS) 1997, 233-237.
63. Fu C., Rummler Z., Schomburg W. magnetically driven micro ball valves fabricated by multilayer adhesive film bonding. J. Micromech. Microeng. 2003, 13.
64. Dubois P., Guldimann B., Rooij N.F.d. High-speed electrostatic gas microvalve switching behavior. Proc. SPIE 2001, 4560.
65. Rich C.A., Wise K.D. A high-flow thermopneumatic microvalve with improved efficiency and integrated state sensing. IEEE/ASME J. Microelectromech. Syst. 2003, 12.
66. Messner S., Muller M., Burger V., Schaible J., Sandmaier H., Zengerle R. A normally-closed, bimetallically actuated 3-way microvalve for pneumatic applications. Proceedings of the IEEE International Conference on Micro Electro Mechanical Systems (MEMS) 1998, 40-44.
67. Kohl M., Dittmann D., Quandt E., Winzek B. Thin film shape memory microvalves with adjustable operation temperature. Sensor Actuat. A-Phys. 2000, 83.
68. Esashi M., Shoji S., Nakano A. Normally closed microvalve and micropump fabricated on a silicon wafer. Sensor Actuat. A-Phys. 1989, 20.
69. Yang X., Holke A., Jacobson S.A., Lang J.H., Schmidt M.A., Umans S.D. An electrostatic, on/off microvalve designed for gas fuel delivery for the MIT microengine. IEEE/ASME J. Microelectromech. Syst. 2004, 13:660-668.
70. Chakraborty I., Tang W.C., Bame D.P., Tang T.K. MEMS micro-valve for space application. Sensor Actuat. A-Phys. 2000, 83.
71. Roberts D.C., Hanqing L., Steyn J.L., Yaglioglu O., Spearing S.M., Schmidt M.A., Hagood N.W. A piezoelectric microvalve for compact high-frequency, high-differential pressure hydraulic micropumping systems. IEEE/ASME J. Microelectromech. Syst. 2003, 12.
72. Brosten T.R., Park J.M., Evans A.T., Rasmussen K., Nellis G.F., Klein S.A., Feller J.R., Salerno L., Gianchandani Y.B. A numerical flow model and experimental results of a cryogenic micro-valve for distributed cooling applications. Cryogenics 2007, 47:501-509.
73. Park J.M., Evans A.T., Rasmussen K., Brosten T.R., Nellis G.F., Klein S.A., Gianchandani Y.B. A microvalve with integrated sensors and customizable normal state for low temperature operation. IEEE/ASME J. Microelectromech. Syst. 2009, 18:868-879.
74. Magnes B. Body position and cerebrospinal fluid pressure. Part I: clinical studies on the effect of rapid postural changes. J. Neurosurg. 1976, 44:687-697.
75. Medtronic, Medtronic SynchroMed II Programmable Infusion System Implant Manual http://professional.medtronic.com/wcm/groups/mdtcom_sg/@mdt/@neuro/documents/documents/pump-ii8637-impmanl.pdf.
76. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet. Med. 2006, 23:1-12.
77. Mastrototaro J.J., Cooper K.W., Soundararajan G., Sanders J.B., Shah R.V. Clinical experience with an integrated continuous glucose sensor/insulin pump platform: a feasibility study. Adv. Ther. 2006, 23:725-732.
78. Hirsch I.B., Abelseth J., Bode B.W., Fischer J.S., Kaufman F.R., Mastrototaro J., Parkin C.G., Wolpert H.A., Buckingham B.A. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol. Ther. 2008, 10:377-383.
79. Clark J.L.C., Lyons C., Aead A.N.Y. Electrode systems for continuous monitoring in cardiovascular surgery. Science 1962, 102:29-45.
80. Reach G., Wilson G.S. Can continuous glucose monitoring be used for the treatment of diabetes. Anal. Chem. 1992, 64:381A-386A.
81. Turner A.P.F., Chen B., Piletsky S.A. In vitro diagnostics in diabetes: meeting the challenge. Clin. Chem. 1999, 45:1596-1601.
82. Kissinger P.T. Biosensors-a perspective. Biosens. Bioelectron. 2005, 20:2512-2516.
83. Newman J.D., Turner A.P.F. Home blood glucose biosensors: a commercial perspective. Biosens. Bioelectron. 2005, 20:2435-2453.
84. Ricci F., Palleschi G. Sensor and biosensor preparation, optimisation and applications of Prussian Blue modified electrodes. Biosens. Bioelectron. 2005, 21:389-407.
85. Wilson G.S., Gifford R. Biosensors for real-time in vivo measurements. Biosens. Bioelectron. 2005, 20:2388-2403.
86. Pickup J.C., Hussain F., Evans N.D., Sachedina N. In vivo glucose monitoring: the clinical reality and the promise. Biosens. Bioelectron. 2005, 20:1897-1902.
87. Wang J. Electrochemical glucose biosensors. Chem. Rev. 2008, 108:814-825.
88. Wilson R., Turner A.P.F. Glucose oxidase: an ideal enzyme. Biosens. Bioelectron. 1992, 7:165-185.
89. Shoji E., Freund M.S. Potentiometric sensors based on the inductive effect on the pKa of poly(aniline): a nonenzymatic glucose sensor. J. Am. Chem. Soc. 2001, 123:3383-3384.
90. Park S., Boo H., Chung T.D. Electrochemical nonenzymatic glucose sensors. Anal. Chim. Acta 2006, 556:46-57.
91. Babu T.G.S., Ramachandran T., Nair B. Single step modification of copper electrode for the highly sensitive and selective non-enzymatic determination of glucose. Microchim. Acta 2010, 169:49-55.
92. Babu T.G.S., Suneesha P.V., Ramachandrana T., Nair B. Gold nanoparticles modified titania nanotube arrays for amperometric determination of ascorbic acid. Anal. Lett. 2010, 43:2809-2822.
93. Babu T.G.S., Ramachandrana T. Development of highly sensitive non-enzymatic sensor for the selective determination of glucose and fabrication of a working model. Electrochim. Acta 2010, 55:1612-1618.
94. Carmichael M. The changing science of pain. Newsweek Jun. 4, 2007.
95. B.R. Boveja, A. Widhany, Method and system for providing pulsed electrical stimulation to provide therapy for erectile/sexual dysfunction, prostatitis, prostatitis pain, and chronic pelvic pain, U.S. Patent No. 7,330,762, 2008.
96. R. Vipul, Vipul's lifetime lifeline permanent pacemaker and implantable cardioverter-defibrillator, U.S. Patent No. 7,239,917, 2007.
97. Reynaerts D., Peirs J., Brussel H.V. A SMA-actuated implantable system for delivery of liquid drugs. Proceedings of the Fifth International Conference on New Actuators 1996.
98. Andrews J.C., Walker-Andrews S.C., Ensminger W.D. Long-term central venous access with a peripherally placed subcutaneous infusion port: initial results. Radiology 1990, 176.
99. Strum S., McDermed J., Korn A., Joseph C. Improved methods for venous access: the Port-A-Cath, a totally implanted catheter system. J. Clin. Oncol. 1986, 4.
100. Morris S.L., Jaques P.F., Mauro M.A. Radiology-assisted placement of implantable subcutaneous infusion ports for long-term venous access. Radiology 1992, 184.
101. Evans A.T., Chiravuri S., Gianchandani Y. Transdermal power transfer for recharging implanted drug delivery devices via the refill port. Biomed. Microdevices 2010, 12:179-185.
102. Kim H., Najafi K. Characterization of low-temperature wafer bonding using thin-film Parylene. IEEE/ASME J. Microelectromech. Syst. 2005, 14:1347-1355.
103. Hovorka R., Allen J.M., Elleri D., Chassin L.J., Harris J., Xing D., Kollman C., Hovorka T., Larsen A.M.F., Nodale M., De Palma A., Wilinska M.E., Acerini C.L., Dunger D.B. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010, 375:743-751.
104. Bruttomesso D., Farret A., Costa S., Marescotti M.C., Vettore M., Avogaro A., Tiengo A., Man C.D., Place J., Facchinetti A., Guerra S., Magni L., Nicolao G.D., Cobelli C., Renard E., Maran A. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J. Diabetes Sci. Technol. 2009, 3:1014-1021.
105. The bionic pancreas for type I diabetics Accessed Aug. 2011. http://www3.imperial.ac.uk/bioinspiredtechnology/research/bionicpancreas.